Major decrease in the volume of the entorhinal cortex in patients with Alzheimer's disease carrying the apolipoprotein E ε4 allele

Journal of Neurology Neurosurgery and Psychiatry

Volumn 65, Issue 3, 1998, Pages 322-327

  Juottonen, K ^a   Lehtovirta, M ^a   Helisalmi, S ^a,b   Riekkinen Sr , P J ^a,c   Soininen, H ^a,c  

^a Department of Neuroscience and Neurology ^*

^b University Hospital

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Alzheimer's disease; ApoE; Entorhinal cortex; Memory; MRI

Indexed keywords

AMYLOID; APOLIPOPROTEIN E4;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN ATROPHY; BRAIN SIZE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENTORHINAL CORTEX; FEMALE; HISTOLOGY; HUMAN; MALE; NEUROFIBRILLARY TANGLE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RISK FACTOR; SENILE PLAQUE; SEX DIFFERENCE; TEMPORAL LOBE; VERBAL MEMORY; VISUAL MEMORY;

EID: 0031682727     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.65.3.322     Document Type: Article

References (54)

1. Schmechel DE, Saunders AM, Strittmatter WJ, et al. Increased amyloid β-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc Natl Acad Sci 1993;90:9649-53.
2. Rebeck GW, Reiter JS, Strickland DK, et al. Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions. Neuron 1993;11:575-80.
3. Nagy Z, Esiri MM, Jobst KA, et al. Influence of the apolippprotein E genotype on amyloid deposition and neurofibrillary tangle formation in Alzheimer's disease. Neuroscience 1995;69:757-61.
4. Soininen H, Kosunen O, Helisalmi S, et al. A severe loss of choline acetyltransferase in the frontal cortex of Alzheimer patients carrying apolipoprotein epsilon 4 allele. Neurosci Lett 1995;187:79-82.
5. Poirier J. Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease. Trends Neurosci 1994;17:525-30.
6. Arendt T, Schindler C, Bruckner MK, et al. Plastic neuronal remodeling is impaired in patients with Alzheimer's disease carrying apolipoprotein ε4 allele. J Neurosci 1997;17:516-29.
7. Soininen HS, Riekkinen PJ Sr. Apolipoprotein E, memory and Alzheimer's disease. Trends Neurosci 1996;19:224-8.
8. Lehtovirta M, Laakso MP, Soininen H, et al. Volumes of hippocampus, amygdala, and frontal lobe in Alzheimer-patients with different apolipoprotein E genotypes. Neuroscience 1995;67:65-72.
9. Soininen H, Partanen K, Pitkanen A, et al. Decreased hippocampal volume asymmetry on MRI scans in non-demented elderly subjects carrying apolipoprotein E 4 allele. Neurology 1995;45:391-2.
10. Kesslak JP, Nalcioglu O, Cotman CW. Quantification of magnetic resonance scans for hippocampal and parahippocampal atrophy in Alzheimer's disease. Neurology 1991; 41:51-4.
11. Jack CR, Petersen RC, O'Brien PC, et al. MR-based hippocampal volumetry in the diagnosis of Alzheimer's disease. Neurology 1992;42:183-8.
12. Killiany RJ, Moss MB, Albert MS, et al. Temporal lobe regions on magnetic resonance imaging identity patients with early Alzheimer's disease. Arch Neurol 1993;50:949-54.
13. Lehéricy S, Baulac M, Chiras J, et al. Amygdalohippocampal MR volume measurements in the early stages of Alzheimer disease. Am J Neuroradiol 1994;15:929-37.
14. Laakso MP, Soininen H, Partanen K, et al. Volumes of hippocampus, amygdala and frontal lobes in the MRI-based diagnosis of early Alzheimer's disease: correlation with memory functions. J Neural Transm (P-D-Sect) 1995; 9:73-86.
15. Fox NC, Warrington EK, Freenborough PA, et al. Presymptomatic hippocampal atrophy in Alzheimer's disease. Brain 1996;119:2001-7.
16. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991;82:239-59.
17. Juottonen K, Laakso MP, Insausti R, et al. Volumes of entorhinal and perirhinal cortices in Alzheimer's disease. Neurobiol Aging 1998;19:15-22.
18. McKhann G, Drachman D, Holstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-44.
19. Koivisto K, Reinikainen KJ, Hänninen T, et al. Prevalence of age-associated memory impairment in a randomly selected population from eastern Finland. Neurology 1995;45:741-7.
20. Rosen WG, Terry RD, Fuld PA, et al. Pathological verification of ischemic score in differentiation of dementias. Ann Neurol 1980;7:486-8.
21. Folstein MF, Folstein SE, McHugh PR. Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatry Res 1975;12:189-98.
22. Hughes CP, Berg L, Danziger WL, et al. A new clinical scale for the staging of dementia. Br J Psychiatry 1982;140:566-72.
23. Helkala EL, Laulumaa V, Soininen H, et al. Recall and recognition on memory in patients with Alzheimer's and Parkinson's diseases. Ann Neurol 1988;24:214-17.
24. Millber WP, Hebben N, Kaplan E. The Boston process approach to neuropsychological assessment. In: Grant I, Adams KM, eds. Neuropsychological assessment of neuropsychiatric disorders. New York: Oxford University Press, 1986: 65-86.
25. Russell EW. A multiple scoring method for the assessment of complex memory functions. J Consult Clin Psychol 1975; 43:800-9.
26. Hixon JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 1990;31:545-8.
27. Insausti R, Tunon T, Sobreviela T, et al. The human entorhinal cortex: a cytoarchitectonic analysis. J Comp Neurol 1995;355:171-98.
28. Insausti R, Juottonen K, Soininen H, et al. MRI based analysis of the human entorhinal and perirhinal cortex. AJNR Am J Neuroradiol 1998;19:569-71.
29. Laakso MP, Partanen K, Riekkinen P, et al. Hippocampal volumes in Alzheimer's disease, Parkinson's disease with and without dementia, and in vascular dementia: an MRI study. Neurology 1996;46:678-81.
30. Gomez-Isla T, Price J L, McKeel D W Jr, et al. Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease. J Neurosci 1996;16:4491-500.
31. Payami H, Montee KR, Kaye JA, et al. Alzheimer's disease, apolipoprotein E4, and gender [letter]. JAMA 1994;27: 1316-17.
32. Payami H, Zareparsi S, Montee KR, et al. Gender difference in apolipoprotein E-associated risk for familial Alzheimer disease: a possible clue to the higher incidence of Alzheimer disease in women. Am J Hum Genet 1996;58:803-11.
33. Murphy LC, Wang M, Coutt A, et al. Novel mutations in the estrogen receptor messenger RNA in human breast cancers. J Clin Endocrinol Metab 1996;81:1420-7.
34. Gould E, Woolley CS, Frankfurt M, et al. Gonadal steroids regulate dendritic spine density in hippocampal pyramidal cells in adulthood. J Neurosci 1990;10:1286-91.
35. Luine VN. Estradiol increases choline acetyltransferase activity in specific basal forebrain nuclei and projection areas of female rats. Exp Neurol 1985;89:484-90.
36. Toran-Allerand CD, Miranda RC, Bentham WD, et al. Estrogen receptors colocalize with low-affinity nerve growth factor receptors in cholinergic neurons of the basal forebrain. Proc Natl Acad Sci 1992;89:4668-72.
37. Singh M, Meyer EM, Simpkins JW. The effect of ovariectomy and estradiol replacement on brain-derived neurotrophic factor messenger ribonucleic acid expression in cortical and hippocampal brain regions of female Sprague-Dawley rats. Endocrinology 1995;136:2320-4.
38. Lehtovirta M, Soininen H, Helisalmi S, et al. Clinical and neuropsychological characteristics in familial and sporadic Alzheimer's disease: relation to apolipoprotein E polymorphism. Neurology 1996;46:413-19.
39. Helkala EL, Koivisto K, Hanninen T, et al. Memory functions in human subjects with different apolipoprotein E phenotypes during a 3 year population based follow up study. Neurosci Lett 1996;204:177-80.
40. Alvarez P, Zola-Morgan S, Squire LR. Damage limited to the hippocampal region produces long lasting memory impairment in monkeys. J Neurosci 1995;15:3796-807.
41. Leonard BW, Amaral DG, Squire LR, et al. Transient memory impairment in monkeys with bilateral lesions of the entorhinal cortex. J Neurosci 1995;15:5637-59.
42. Corder EH, Saunders AM, Strittmatter WJ, et al. The apolipoprotein E E4 allele and sex-specific risk of Alzheimer's disease [letter]. JAMA 1995;273:373-4.
43. Strittmatter WJ, Saunders AM, Schmechel D, et al. Apolipoprotein E: high-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci 1993;90:1977-81.
44. Namba Y, Tomonaga M, Kawasaki H, et al. Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res 1991;541: 163-6.
45. Schmechel DE, Saunders AM, Strittmatter WJ, et al. Increased amyloid β-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc Natl Acad Sci 1993;90: 9649-53.
46. Hyman BT, Damasio AR, Van-Hoesen GW, et al. Alzheimer's disease: cell-specific pathology isolates the hippocampal formation. Science 1984;298:83-95.
47. Rebeck GW, Reiter JS, Strickland DK, et al. Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions. Neuron 1993;11:575-80.
48. Polvikoski T, Sulkava R, Haltia M, et al. Apolipoprotein E, dementia, and cortical deposition of β-amyloid protein. N Engl J Med 1995;333:1242-7.
49. Strittmatter WJ, Weisgraber KH, Goedert M, et al. Hypothesis: microtubule instability and paired helical filament formation in the Alzheimer disease brain are related to apolipoprotein E genotype. Exp Neurol 1994;125: 163-71.
50. Poirier J, Baccichet A, Dea D, et al. Cholesterol synthesis and lipoprotein reuptake during synaptic remodelling in hippocampus in adult rats. Neuroscience 1993;55:81-90.
51. Davignon J, Gregg RE, Sing CR Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 1988;8: 1-21.
52. Ignatius MJ, Gebicke-Harter PJ, Skene JH, et al. Expression of apolipoprotein E during nerve degeneration and regeneration. Proc Natl Acad Sci 1986;83:1125-9.
53. Poirier J, Hess M, May PC, et al. Astrocytic apolipoprotein E mRNA and GFAP mRNA in hippocampus after entorhinal cortex lesioning. Brain Res Mol Brain Res 1991;11:97-106.
54. Petersen RC, Smith GE, Ivnik RJ, et al. Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals. JAMA 1995;273: 1274-8.